Outcomes of Ultra-radical Surgery in Ovarian Cancer with Sahar Salehi

BMJ talk medicine

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Sr. Sahar Salehi to discuss outcomes of ultra-radical surgery in ovarian cancer. Dr. Salehi is the Director of ovarian cancer surgery at Karolinska University Hospital, in Stockholm, Sweden, as well as an Assistant Professor at the Department of Microbiology, Tumor and Cellbiology at Karolinska Institutet. • A shift to ultra-radical surgery does not improve survival despite increased complete resection rates, for this reason complete resection may not be the absolute aim in a high surgical proficiency setting. • A shift to ultra-radical surgery increase the proportion of non-surgically treated women. • The majority of women with cancer in the abdomen of unknown origin (inoperabel/non-resectable women/women who might not meet a gynecologic oncologist) are ovarian cancer patients. • There is an urgent need to calibrate selection of patients to surgery (and to which extent of surgery) in more detail.